Prevalence of Thyroid Disorders in Patients With Immune Thrombocytopenic Purpura and Its Impact on Treatment
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
Prevalence of thyroid disorders in patients with immune thrombocytopenic purpura and its impact on treatment
Eligibility criteria
Qualifiers
ITP patients will be classified as newly diagnosed, persistent and chronic based on duration less than 3 months, 3-12 months, and more than 12 months respectively.
refractory ITP patients.
Disqualifiers
patients with history of thyroidectomy
patients with history of drug induced ITP
patients with history of HCV, HBV and HIV infection.
Patients who refuse to contribute in this study.
Trial design
Treatments tested in this trial
- Search for thyroid disorders
- Laboratory test
- Steroid and eltrombopage
Treatment groups
100 Participants
are divided into 1 treatment groupLocations
Sponsors and collaborators
Source ClinicalTrials.gov